These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 23865735)
1. Large normal alleles and SCA2 prevalence: lessons from a nationwide study and analysis of the literature. Laffita-Mesa JM; Almaguer-Mederos LE; Kourí V; Bauer PO; Vázquez-Mojena Y; Cruz Mariño T; Velázquez-Pérez L Clin Genet; 2014 Jul; 86(1):96-8. PubMed ID: 23865735 [No Abstract] [Full Text] [Related]
2. Unexpanded and intermediate CAG polymorphisms at the SCA2 locus (ATXN2) in the Cuban population: evidence about the origin of expanded SCA2 alleles. Laffita-Mesa JM; Velázquez-Pérez LC; Santos Falcón N; Cruz-Mariño T; González Zaldívar Y; Vázquez Mojena Y; Almaguer-Gotay D; Almaguer Mederos LE; Rodríguez Labrada R Eur J Hum Genet; 2012 Jan; 20(1):41-9. PubMed ID: 21934711 [TBL] [Abstract][Full Text] [Related]
6. Luis Velázquez-Pérez: helping to put SCA2 in the spotlight. Holmes D Lancet Neurol; 2014 May; 13(5):449. PubMed ID: 24739243 [No Abstract] [Full Text] [Related]
7. [Hereditary ataxias in Cuba. Historical, epidemiological, clinical, electrophysiological and quantitative neurological features]. Velázquez-Pérez L; García R; Santos FN; Paneque HM; Medina HE; Hechavarría PR Rev Neurol; 2001 Jan 1-15; 32(1):71-6. PubMed ID: 11293106 [TBL] [Abstract][Full Text] [Related]
8. Are (CTG)n expansions at the SCA8 locus rare polymorphisms? Stevanin G; Herman A; Dürr A; Jodice C; Frontali M; Agid Y; Brice A Nat Genet; 2000 Mar; 24(3):213; author reply 215. PubMed ID: 10700167 [No Abstract] [Full Text] [Related]
9. The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Cruz-Mariño T; Velázquez-Pérez L; González-Zaldivar Y; Aguilera-Rodríguez R; Velázquez-Santos M; Vázquez-Mojena Y; Estupiñán-Rodríguez A; Laffita-Mesa JM; Reynaldo-Armiñán R; Almaguer-Mederos LE; Paneque M Clin Genet; 2013 Jun; 83(6):518-24. PubMed ID: 23495852 [TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis. Mutesa L; Pierquin G; Segers K; Vanbellinghen JF; Gahimbare L; Bours V J Trop Pediatr; 2008 Oct; 54(5):350-2. PubMed ID: 18499737 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress as a cofactor in spinocerebellar ataxia type 2. Guevara-García M; Gil-del Valle L; Velásquez-Pérez L; García-Rodríguez JC Redox Rep; 2012; 17(2):84-9. PubMed ID: 22564351 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism at spinocerebellar ataxia 1 and 2 loci in Brazil. Duarte SF; Gestinari RS; Campos Junior M; Pimentel MM; Lima MA Genet Mol Res; 2003 Dec; 2(4):360-5. PubMed ID: 15011139 [TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of spinocerebellar ataxia type 6. Craig K; Keers SM; Archibald K; Curtis A; Chinnery PF Ann Neurol; 2004 May; 55(5):752-5. PubMed ID: 15122720 [TBL] [Abstract][Full Text] [Related]
14. Gene dosage influences the age at onset of SCA2 in a family from southern Italy. Spadafora P; Annesi G; Liguori M; Tarantino P; Cutuli N; Carrideo S; Cirò Candiano IC; De Marco EV; Civitelli D; Annesi F; Giuffrida S; Quattrone A Clin Genet; 2007 Oct; 72(4):381-3. PubMed ID: 17850638 [No Abstract] [Full Text] [Related]
15. Minimum prevalence of spinocerebellar ataxia 17 in the north east of England. Craig K; Keers SM; Walls TJ; Curtis A; Chinnery PF J Neurol Sci; 2005 Dec; 239(1):105-9. PubMed ID: 16223509 [TBL] [Abstract][Full Text] [Related]
16. Comparative multiplex dosage analysis in spinocerebellar ataxia type 2 patients. Calì F; Chiavetta V; Ragalmuto A; Vinci M; Ruggeri G; Schinocca P; Romano V Genet Mol Res; 2013 Apr; 12(2):1176-81. PubMed ID: 23661442 [TBL] [Abstract][Full Text] [Related]
17. SCA2 alleles are not general predisposition factors for multiple sclerosis. Miterski B; Eppelen JT; Poehlau D; Sindern E; Haupts M Neurogenetics; 2000 Mar; 2(4):235-6. PubMed ID: 10983720 [No Abstract] [Full Text] [Related]
18. Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis. Almaguer-Mederos LE; Falcón NS; Almira YR; Zaldivar YG; Almarales DC; Góngora EM; Herrera MP; Batallán KE; Armiñán RR; Manresa MV; Cruz GS; Laffita-Mesa J; Cyuz TM; Chang V; Auburger G; Gispert S; Pérez LV Clin Genet; 2010 Aug; 78(2):169-74. PubMed ID: 20095980 [TBL] [Abstract][Full Text] [Related]
19. Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba. Paneque M; Lemos C; Escalona K; Prieto L; Reynaldo R; Velázquez M; Quevedo J; Santos N; Almaguer LE; Velázquez L; Sousa A; Fleming M; Sequeiros J J Genet Couns; 2007 Aug; 16(4):469-79. PubMed ID: 17318452 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2. Simon DK; Zheng K; Velázquez L; Santos N; Almaguer L; Figueroa KP; Pulst SM Arch Neurol; 2007 Jul; 64(7):1042-4. PubMed ID: 17620498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]